Pharmaceuticals & Biotechnology (4570)

20,642.14
   
  • 52 Week High: 24,649.93
  • 52 Week Low: 18,687.04

Latest ShareCast News

GSK, Spero UTI drug trial ends early after meeting target

By Frank Prenesti

Date: Wednesday 28 May 2025

(Sharecast News) - UK pharma giant GSK and its partner Spero Therapeutics on Wednesday said it had ended a late-stage trial of an experimental drug for complicated urinary tract infections early after it met its main target.

Pharmaceuticals & Biotechnology Regulatory News

Results of Haleon 2025 Annual General Meeting 28-May-2025 18:00 RNS
Form 8.3 - BENCHMARK HOLDINGS PLC 28-May-2025 12:38 RNS
GSK stops Phase 3 trial on cUTIs for efficacy 28-May-2025 12:00 RNS
Form 8.3 - BENCHMARK HOLDINGS PLC 28-May-2025 11:06 RNS
Form 8.3 - Benchmark Holdings plc 28-May-2025 10:49 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 20,642.14
Closing Price Change -110.16
% Change -0.53 %
28-May-25 Close 20,642.14

Top Risers

Price Change
NFX 0.16p +71.1%
CIZ 2.05p +13.9%
AVCT 35.00p +12.9%
FARN 245.00p +7.5%
PRM 3.34p +6.4%
INDV 900.00p +4.6%
HELD 0.99p +4.2%
TCF 0.28p +3.8%
AREC 43.00p +3.6%
IXI 12.00p +2.1%

Top Fallers

Price Change
APTA 0.34p -8.1%
ONT 124.10p -5.9%
HCM 198.50p -5.5%
OXB 312.00p -5.0%
AGY 7.20p -3.4%
ANIC 6.38p -3.3%
SBTX 18.75p -2.6%
POLB 3.75p -2.6%
LLAI 4.15p -2.4%
OPTI 14.75p -1.7%

Top of Page